Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 209,154 | 221,172 | 165,317 | 171,017 | 182,898 |
| Marketable Securities | 129,192 | 156,706 | 197,166 | 203,210 | 238,104 |
| Receivables | N/A | N/A | 5,000 | N/A | N/A |
| TOTAL | $345,814 | $384,516 | $371,055 | $377,733 | $424,597 |
| Non-Current Assets | |||||
| PPE Net | 1,585 | 1,495 | 1,610 | 1,618 | 1,695 |
| Investments And Advances | 36,177 | 14,321 | 50,215 | 54,305 | 23,418 |
| Other Non-Current Assets | 1,174 | 1,414 | 1,353 | 1,541 | 1,795 |
| TOTAL | $38,936 | $17,230 | $53,178 | $57,464 | $26,908 |
| Total Assets | $384,750 | $401,746 | $424,233 | $435,197 | $451,505 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,484 | 6,289 | 8,571 | 16,237 | 10,522 |
| Accrued Expenses | 18,139 | 12,916 | 13,781 | 11,052 | 15,286 |
| Other current liabilities | 851 | 925 | 898 | 871 | 845 |
| TOTAL | $24,474 | $20,130 | $23,250 | $29,535 | $29,730 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 33 | 180 | 419 | 654 | 883 |
| TOTAL | $33 | $180 | $419 | $654 | $883 |
| Total Liabilities | $24,507 | $20,310 | $23,669 | $30,189 | $30,613 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,348 | 27,304 | 27,277 | 27,265 | 27,133 |
| Common Shares | 27 | 27 | 27 | 27 | 27 |
| Retained earnings | -297,603 | -273,836 | -252,288 | -244,026 | -223,763 |
| Other shareholders' equity | 259 | 753 | 1,145 | 338 | 480 |
| TOTAL | $360,243 | $381,436 | $400,564 | $405,008 | $420,892 |
| Total Liabilities And Equity | $384,750 | $401,746 | $424,233 | $435,197 | $451,505 |